Form 8-K - Current report:
SEC Accession No. 0001558370-25-000025
Filing Date
2025-01-06
Accepted
2025-01-06 08:05:15
Documents
14
Period of Report
2025-01-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K fbio-20250106x8k.htm   iXBRL 8-K 39754
  Complete submission text file 0001558370-25-000025.txt   196571

Data Files

Seq Description Document Type Size
2 EX-101.SCH fbio-20250106.xsd EX-101.SCH 4555
3 EX-101.DEF fbio-20250106_def.xml EX-101.DEF 14890
4 EX-101.LAB fbio-20250106_lab.xml EX-101.LAB 17165
5 EX-101.PRE fbio-20250106_pre.xml EX-101.PRE 14855
16 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20250106x8k_htm.xml XML 7160
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 25509100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)